Literature DB >> 3458863

Staphylococcus aureus-derived chemoattractant activity for human monocytes.

A Rot, L E Henderson, E J Leonard.   

Abstract

Products of bacteria are potent chemoattractants for mammalian leukocytes. Several reports suggest that these attractants are small peptides. We compared the properties of culture fluids of Staphylococcus aureus with fMet-Leu-Phe, considered a prototype of bacterial attractant. Chemotactic activity for human monocytes of Staph. aureus culture filtrates was determined in multiwell chemotaxis chambers. At optimal concentrations, the filtrate attracted almost twice as many monocytes as fMet-Leu-Phe (53 +/- 5% of input number compared with 30 +/- 3%, in a series of ten experiments). Gel-filtration characteristics and susceptibility to proteolytic digestion suggested that chemotactic activity was due to peptides with a molecular size range of 500-2,000 daltons. Reverse-phase high-pressure liquid chromatography (HPLC) of unfractionated filtrate revealed nine peaks of chemotactic activity, most of which was in five of the peaks. One peak accounted for 40% of total activity. Individual peaks, like the unfractionated material, were capable of attracting about twice as many monocytes as the optimal concentration of fMet-Leu-Phe. Quantitative bioassay of the HPLC peaks showed that only 5% of the total Staph. aureus chemotactic activity eluted in the position of fMet-Leu-Phe. This is in contrast to the report that fMet-Leu-Phe accounted for 70% of neutrophil lysosomal enzyme-releasing activity of Escherichia coli culture fluid. In summary, chemotactic activity for monocytes of Staph. aureus culture fluid is due to peptides other than fMet-Leu-Phe; these peptides recruit a higher percentage of monocytes than fMet-Leu-Phe.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458863     DOI: 10.1002/jlb.40.1.43

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.

Authors:  A Rot; L E Henderson; T D Copeland; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes.

Authors:  H Nielsen; L P Andersen
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

3.  Preliminary estimation of chemoattractant activity of staphylococcal serine proteinase in vitro. Chemoattractant activity of staphylococcal serine proteinase.

Authors:  K Baran; J Midzobrodzki; Z Porwit-Bóbr
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

Review 4.  Recognition of Staphylococcus aureus by the innate immune system.

Authors:  Bénédicte Fournier; Dana J Philpott
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils.

Authors:  P M Craig; M C Territo; W E Karnes; J H Walsh
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

6.  Porphyromonas gingivalis Produce Neutrophil Specific Chemoattractants Including Short Chain Fatty Acids.

Authors:  Agnes Dahlstrand Rudin; Arsham Khamzeh; Vignesh Venkatakrishnan; Tishana Persson; Michael Gabl; Otto Savolainen; Huamei Forsman; Claes Dahlgren; Karin Christenson; Johan Bylund
Journal:  Front Cell Infect Microbiol       Date:  2021-01-19       Impact factor: 5.293

Review 7.  The Role of Macrophages in Staphylococcus aureus Infection.

Authors:  Grace R Pidwill; Josie F Gibson; Joby Cole; Stephen A Renshaw; Simon J Foster
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

8.  Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.

Authors:  U E Mai; G I Perez-Perez; J B Allen; S M Wahl; M J Blaser; P D Smith
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.